Not recruiting
Glomerulonephritis membranoproliferative+1
Not recruitingRegistered drugNo placebo
Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
Registered drugNo placebo
- Disease:Glomerulonephritis membranoproliferativeC3 glomerulopathy
- Substances:PegcetacoplanN. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid+30
Countries:
The Netherlands
The Netherlands- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Pegcetacoplan
